RPG Life Sciences reported a 16.5% year-on-year increase in revenue from operations to ₹211.6 crore in the second quarter of FY27. Adjusted EBITDA, excluding one-off costs related to the API acquisitions and restructuring, rose 15% to ₹50.1 crore, as per the company. Research-based pharmaceutical firm RPG Life Sciences reported a 16.5% year-on-year increase in revenue from operations to ₹211.6 crore in the second quarter of FY27.The company reported a profit of ₹28.